Building Better Immunotherapy
At first glance, the vial nesting in a laboratory tray at Duke University School of Medicine looks like any other. But inside something remarkable is happening. A new kind of cancer-fighting cell is taking shape that might finally crack one of medicine’s most frustrating challenges: how to make immunotherapy work against solid cancer tumors. (continued)
Beth Shaz, MD Receives AABB Foundation 2025 Process Development Grant
The AABB Foundation Process Development Grant provides funding to enhance the efficiency and effectiveness of blood- and biotherapies-related processes and operations in donor and patient care settings.
The Process Development Grant supports improvements to business operations through the development, implementation and outcomes analysis of innovative processes, techniques or technologies.
Kurtzberg and Filiano to Present at 2025 AABB Conference in San Diego
Joanne Kurtzberg, MD and Tony Filiano, PhD, will be presenting at the 2025 Association for the Advancement of Blood & Biotherapies conference this October in San Diego. Kurtzberg's presentation will discuss contemporary controversies and barriers that have prevented the cord blood sector from maximizing its full potential, in terms of impact on the lives of families and patients and in accelerating scientific innovation.
Filiano's session will focus on the expanding role of umbilical cord blood in regenerative medicine, highlighting its potential beyond hematopoietic stem cell transplantation. Filiano, along with others, will discuss cutting-edge research, clinical applications, and future directions for using cord blood-derived cells in treating a wide range of diseases.